Exosome-based therapy for atopic dermatitis: translational status, clinical evidence, and regulatory reality
Objectives To evaluate the translational rationale, published clinical evidence, investigational development, and regulatory considerations for extracellular vesicle (EV; frequently described as exosome) therapy in atopic dermatitis (AD).Methods We conducted a narrative review of PubMed, Web of Science, and Google Scholar from inception through August 2026, supplemented by reference screening and ClinicalTrials.gov searches. Experimental studies, human reports, and investigational trial records were assessed separately.Results Thirty experimental studies reported improvements in barrier-related or inflammatory outcomes in cellular and animal models, although EV sources, characterization, dosing, and delivery differed substantially. Published human evidence was limited to three uncontrolled reports (42 patients): 22 with dupilumab-associated facial redness and 20 with facial AD. No published randomized controlled efficacy trial of EV therapy for human AD was identified. Subcutaneous BxC-I17e has entered phase 1 investigation, but publicly available efficacy findings remain limited to conference reporting. Major limitations include incomplete EV characterization, lack of validated potency assays, uncertain topical penetration, and insufficient long-term safety data. No exosome product is approved by the US Food and Drug Administration.Conclusions Although EV preparations show preclinical promise, evidence is insufficient to recommend their routine use for AD. Product-specific, randomized controlled trials with standardized manufacturing and robust safety assessments are required.
Authors
- Almuntsrbellah M. Almudimeegh (ORCID: https://orcid.org/0009-0006-8931-2183)
- Naif Jameel Alshehri (ORCID: https://orcid.org/0009-0004-4248-8312)
- Khalid Nabil Nagshabandi (ORCID: https://orcid.org/0009-0008-6577-6463)
Institutions
- King Saud University (SA)
Publication Details
- Journal
- Journal of Dermatological Treatment
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1080/09546634.2026.2761113
- Primary Topic
- Extracellular vesicles in disease
- Type
- article
- Field-Weighted Citation Impact
- 0.00